The demand for neurodiagnostic products is expected to grow mainly due to factors such as the increasing prevalence of neurological disorders & diseases, technological advancements, growing patient emphasis on effective & early disease diagnosis, the growing number of diagnostic centers & hospitals, and the use of biomarker profiling for disease diagnostics. These factors have prompted market players to improve and strengthen their current manufacturing and distribution capabilities—especially in emerging markets, which are expected to witness the highest growth.
The report Neurodiagnostics
Market is expected to reach USD 8.4 billion by
2024 from USD 5.9 billion in 2019, at a CAGR of 7.3%.
The diagnostic imaging systems segment accounted for the largest
share of the neurodiagnostics market, by product, in 2018.
Based on the product, the neurodiagnostics market is segmented
into diagnostic imaging systems, clinical diagnostic instruments, and reagents
and consumables. The diagnostic imaging systems segment accounted for the
largest share of the neurodiagnostics market in 2018. The increasing incidence
and prevalence of neurological disorders and growing R&D in the field of
cerebral and spinal disorders are the major factors driving the growth of this
segment
Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=229090425
The hospitals & surgical centers segment accounted for the
largest share of the neurodiagnostics market, by end-user, in 2018
On the basis of end-user, the neurodiagnostics market is
segmented into hospitals & surgical centers, diagnostic laboratories &
imaging centers, neurology centers, ambulatory care centers (ACCs), and
research laboratories & academic institutes.
In 2018, hospitals & surgical centers accounted for the
largest share of the neurodiagnostics market, mainly due to the financial
capabilities of hospitals to purchase expensive equipment, such as
neurodiagnostic devices.
North America accounted for the largest share of the
neurodiagnostics market in 2018
North America accounted for the largest share of the
neurodiagnostics market in 2018, followed by Europe. This can primarily be
attributed to the presence of a highly developed healthcare system, high
adoption of innovative neurodiagnostic devices among medical professionals, and
the full availability of advanced neurodiagnostic devices.
Request Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=229090425
Top Key Players :
Some of the prominent players in the Neurodiagnostics market
include GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare
(Netherlands), Hitachi, Ltd. (Japan), Canon, Inc. (Japan), Lifelines Neuro
Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La Roche AG
(Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd.
(Russia), Advanced Brain Monitoring (US), Thermo Fisher Scientific, Inc. (US),
Bio-Rad Laboratories (US), QIAGEN N.V. (Netherlands), Nihon Kohden Corporation
(Japan), ANT Neuro (Netherlands), Fonar Corporation (US), Fujirebio (Japan),
DRG Instruments GmbH (Germany), Tecan Trading AG (Switzerland), Motion Lab
Systems, Inc. (US), Rigaku Corporation (Japan), Neusoft Medical Systems Co.,
Ltd. (US), ELMIKO MEDICAL Sp. Z o.o. (Poland) and Ridge Diagnostics (US).
No comments:
Post a Comment